OrganoVIR is a Horizon 2020 Marie Sklodowska Curie Actions Innovative Training Network (MSCA-ITN). Our network exists out of public and private experts, as well as 15 talented Early Stage Researchers, who team up to lead innovation in the field of organoids for virology.
Our mission is to transform the virology landscape and establish human organoids as superior models for virus research.
Organoids
Organoid technology originates from developmental biology and cancer research – fields that have only limited overlap with virology. organovir is the first consortium that brings this expertise together in an innovative programme that will dramatically enhance our understanding of the possibilities of 3D models for virology.
Transforming the Virology Landscape
Establishing human organoids as superior models for virus research, thus replacing animal models and reducing animal use.
Using a multi-disciplinary approach with experts in bioengineering, virology, bio-business, policy, and ethics. Together we develop new organoid models for virology.
Establishing human organoids as superior models for virus research, thus replacing animal models and reducing animal use.
Using a multi-disciplinary approach with experts in bioengineering, virology, bio-business, policy, and ethics. Together we develop new organoid models for virology.
Dasja Pajkrt
Dasja co-coordinates the (management of) the Organovir project and is responsible for the management and execution of Organovir’s training programme.
Katja Wolthers
Katja co-coordinates the (management of) the Organovir project and is responsible for the management and execution of Organovir’s scientific component.
Angelica Reitsma
Angelica is the project manager of Organovir. She is responsible for the overall planning of the project, EU reporting and internal communications.
